Plasma fibronectin level and its association with coronary artery disease and carotid intima-media thickness

Coronary Artery Disease

Volumn 14, Issue 3, 2003, Pages 219-224

  Örem, Cihan ^a   Durmuş, Ismet ^a   Kilinç, Kaǧan ^a   Baykan, Merih ^a   Gökçe, Mustafa ^a   Örem, Asim ^a   Topbaş, Murat ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Common carotid artery; Coronary artery disease; Fibronectin; Intima media thickness

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; FIBRINOGEN; FIBRONECTIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD SAMPLING; COMMON CAROTID ARTERY; CORONARY ARTERY DISEASE; ECHOGRAPHY; FEMALE; HUMAN; IMMUNOASSAY; INTIMA; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; PRIORITY JOURNAL; THICKNESS; TUNICA MEDIA;

EID: 0038290398     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mca.0000066454.28270.fb     Document Type: Article

References (22)

1. Stenman S, Von Smitten K, Vaheri A. Fibronectin and atherosclerosis. Acta Med Scand 1980; 642:165-170.
2. Mosesson MW, Amrani DL. The structure and biological activities of plasma fibronectin. Blood 1980; 56:145-158.
3. Stubbs MT, Lazarchick J, Horger EO. Plasma fibronectin levels in preeclampsia: a possible biochemical marker for vascular endothelial damage. Am Obstet Gynecol 1984; 150:885-887.
4. Humphries MJ, Obara M, Olden K, Yamada KM. Role of fibronectin in adhesion, migration and metastasis. Cancer Invest 1989; 7:373-393.
5. Pearistein E. Plasma membrane glycoprotein which mediates adhesion of fibrobrasts to collagen. Nature 1976; 262:497-500.
6. Sönmez H, Süer S, Kokoǧlu E, Dirican A, Ulutin T, Ucisik N, et al. The importance of Lp(a)-fibronectin interaction in atherogenesis. Haemotologia 1997; 28:149-153.
7. Song KS, Kim HK, Shim W, Jee SH. Plasma fibronectin levels in ischemic heart disease. Atherosclerosis 2001; 154:449-453.
8. Chambless LE, Folsom AR, Davis V, Sharrett R, Heiss G, Sorlie P, et al. Risk factors for progression of common carotid atherosclerosis: the Atherosclerosis Risk in Communities Study, 1987-1998. Am J Epidemiol 2002; 155:38-47.
9. Rossi E, McQuillan BM, Hung J, Thompson PL, Kuek C, Beilby JP. Serum ferritin and C282Y mutation of the hemocromatosis gene as predictors of asymptomatic carotid atheroscrerosis in a community population. Stroke 2000; 31:3015-3020.
10. Lefevre A, Mazurier C, Goudemand M. Comparative study of 3 techniques for the determination of plasma fibronectin. Results in the normal subject. Rev Fr Transfus Immunohematol 1983; 26:135-145.
11. Cucuianu M, Bodizs G, Duncea I, Colhon D. Prasma Fibronectin in men and women: correlation with serum trigryceride levels and serum cholinesterase activity. Blood Coagul Fibrinolysis 1996; 7:779-785.
12. Jadhav UM, Kadam NN. Carotid intima-media thickness as an independent predictor of coronary artery disease. Indian Heart J 2001; 53:458-462.
13. Winbeck K, Kukla C, Poppert H, Klingelhofer J, Conrad B, Sander D. Elevated C-reactive protein is associated with an increased intima media thickness of the common carotid artery. Cerebrovasc Dis 2002; 13:57-63.
14. Wang TJ, Larson MG, Levy D, Benjamin EJ, Kupka MJ, Manning Clouse ME, et al. C-reactive protein is associated with subclinical epicardial coronary calcification in men and women: the Framingham Study. Circulation 2002; 106:1189-1191.
15. Forsom AR, Aleksic N, Catellier D, Juneja HS, Wu KK. C-reactive protein and incident coronary heart disease in the Atherosclerotic Risk In Communities (ARIC) study. Am Heart J 2002; 144:233-238.
16. Ross T. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362:801-809.
17. Libby P. Molecular basis of the acute coronary syndromes. Circulation 1995; 91:2844-2850.
18. Harry YU, Rifai N. High-sensitivity C-reactive protein and atherosclerosis: From theory to therapy. Clin Biochem 2000; 33:601-610.
19. Walton KW, Morris CJ. Studies on the passage of plasma proteins across atrial endothelium in relation to atherogenesis. Prog Biochem Pharmacol 1997; 14:138-152.
20. Cseh K, Karadi I, Rischak K, Szollar L, Janoki G, Jakab L, et al. Binding of fibronectin to human lipoproteins. Clin Chim Acta 1989; 182:75-86.
21. Bartolomei G, Seghieri G, Degiorgio LA, et al. Plasma fibronectin in diabetes. In: Belfiore F, Galton DJ, Reaven GM (editors): Frontiers of diabetes, Vol. 4. Basel: Karger; 1984. pp. 269-272.
22. Falcone DJ, Mated N, Shio H, Minick CR, Fowler SD. Lipoprotein-heparin-fibronectin-denatured collagen complexes enhance cholesteryl ester accumulation in macrophages. J Cell Biol 1984; 99:1266-1274.